Bilateral pneumothorax in a patient with anaplastic thyroid carcinoma and lung metastasis during lenvatinib therapy: a case report
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Ha Na | - |
dc.contributor.author | Chung, Won Sang | - |
dc.contributor.author | Jang, Hyo Jun | - |
dc.contributor.author | Jee, Seungyun | - |
dc.contributor.author | Tae, Kyung | - |
dc.date.accessioned | 2022-07-07T14:34:23Z | - |
dc.date.available | 2022-07-07T14:34:23Z | - |
dc.date.created | 2021-05-12 | - |
dc.date.issued | 2020-10 | - |
dc.identifier.issn | 2227-684X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/145013 | - |
dc.description.abstract | The prognosis of anaplastic thyroid carcinoma (ATC) is very poor. In most patients, ATC presents with cervical lymph node metastasis, and more than 40% of patients have distant metastasis at the time of diagnosis. Lenvatinib, a multi-targeted tyrosine kinase inhibitor, is a novel drug that has antitumor effects on radioactive iodine-refractory papillary cancer and anaplastic cancer. The development of bilateral pneumothorax during targeted therapy is very rare in patients with thyroid cancer. We recently encountered a case of bilateral pneumothorax in a patient with ATC and lung metastasis during lenvatinib therapy. The patient underwent video-assisted thoracoscopic surgery (VATS) in both the lungs because the pneumothorax continued to aggravate even after the insertion of chest tubes. Clinicians need to be aware that the development of pneumothorax is a possibility during lenvatinib therapy for ATC and lung metastasis. The case is reported herein, along with a review of relevant literature. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | AME PUBL CO | - |
dc.title | Bilateral pneumothorax in a patient with anaplastic thyroid carcinoma and lung metastasis during lenvatinib therapy: a case report | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Tae, Kyung | - |
dc.identifier.doi | 10.21037/gs-20-462 | - |
dc.identifier.scopusid | 2-s2.0-85096557676 | - |
dc.identifier.wosid | 000585472600046 | - |
dc.identifier.bibliographicCitation | GLAND SURGERY, v.9, no.5, pp.1579 - 1583 | - |
dc.relation.isPartOf | GLAND SURGERY | - |
dc.citation.title | GLAND SURGERY | - |
dc.citation.volume | 9 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 1579 | - |
dc.citation.endPage | 1583 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Surgery | - |
dc.relation.journalWebOfScienceCategory | Surgery | - |
dc.subject.keywordPlus | GUIDELINES | - |
dc.subject.keywordPlus | MANAGEMENT | - |
dc.subject.keywordAuthor | Thyroid carcinoma | - |
dc.subject.keywordAuthor | anaplastic | - |
dc.subject.keywordAuthor | pneumothorax | - |
dc.subject.keywordAuthor | targeted molecular therapy | - |
dc.subject.keywordAuthor | case report | - |
dc.identifier.url | https://gs.amegroups.com/article/view/51959/html | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.